Cargando…

Peripheral Neuropathy Secondary to Ertapenem Administration for Treatment of Infectious Endocarditis

Ertapenem is a widely used broad-spectrum carbapenem antibiotic active against most species of gram-negative and gram-positive aerobes and anaerobes with specific targeting of the Amp C extended-spectrum beta-lactamases. It is advantageous for its once-daily dosing via IM or IV administration and mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Buckman, Patrick J, Scatton, Carly, Cappola, James J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164356/
https://www.ncbi.nlm.nih.gov/pubmed/37162774
http://dx.doi.org/10.7759/cureus.37253
_version_ 1785038051345432576
author Buckman, Patrick J
Scatton, Carly
Cappola, James J
author_facet Buckman, Patrick J
Scatton, Carly
Cappola, James J
author_sort Buckman, Patrick J
collection PubMed
description Ertapenem is a widely used broad-spectrum carbapenem antibiotic active against most species of gram-negative and gram-positive aerobes and anaerobes with specific targeting of the Amp C extended-spectrum beta-lactamases. It is advantageous for its once-daily dosing via IM or IV administration and minimal side effect profile for the treatment of community-acquired infections. We report an 80-year-old man presenting with reversible peripheral neuropathy following the administration and subsequent discontinuation of ertapenem for the treatment of acute infectious endocarditis. It is especially notable that our patient had less severe (i.e., stage 3) chronic kidney disease as opposed to current literature which only presents similar findings with more advanced kidney disease (stage 4-5). Upon cessation of ertapenem administration, our patient recovered to his baseline motor and sensory status over a period of four days. We believe there to be value in reporting this case, as well as value in reevaluating the current recommendations for ertapenem dosing in those with kidney compromise.
format Online
Article
Text
id pubmed-10164356
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101643562023-05-08 Peripheral Neuropathy Secondary to Ertapenem Administration for Treatment of Infectious Endocarditis Buckman, Patrick J Scatton, Carly Cappola, James J Cureus Internal Medicine Ertapenem is a widely used broad-spectrum carbapenem antibiotic active against most species of gram-negative and gram-positive aerobes and anaerobes with specific targeting of the Amp C extended-spectrum beta-lactamases. It is advantageous for its once-daily dosing via IM or IV administration and minimal side effect profile for the treatment of community-acquired infections. We report an 80-year-old man presenting with reversible peripheral neuropathy following the administration and subsequent discontinuation of ertapenem for the treatment of acute infectious endocarditis. It is especially notable that our patient had less severe (i.e., stage 3) chronic kidney disease as opposed to current literature which only presents similar findings with more advanced kidney disease (stage 4-5). Upon cessation of ertapenem administration, our patient recovered to his baseline motor and sensory status over a period of four days. We believe there to be value in reporting this case, as well as value in reevaluating the current recommendations for ertapenem dosing in those with kidney compromise. Cureus 2023-04-07 /pmc/articles/PMC10164356/ /pubmed/37162774 http://dx.doi.org/10.7759/cureus.37253 Text en Copyright © 2023, Buckman et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Buckman, Patrick J
Scatton, Carly
Cappola, James J
Peripheral Neuropathy Secondary to Ertapenem Administration for Treatment of Infectious Endocarditis
title Peripheral Neuropathy Secondary to Ertapenem Administration for Treatment of Infectious Endocarditis
title_full Peripheral Neuropathy Secondary to Ertapenem Administration for Treatment of Infectious Endocarditis
title_fullStr Peripheral Neuropathy Secondary to Ertapenem Administration for Treatment of Infectious Endocarditis
title_full_unstemmed Peripheral Neuropathy Secondary to Ertapenem Administration for Treatment of Infectious Endocarditis
title_short Peripheral Neuropathy Secondary to Ertapenem Administration for Treatment of Infectious Endocarditis
title_sort peripheral neuropathy secondary to ertapenem administration for treatment of infectious endocarditis
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164356/
https://www.ncbi.nlm.nih.gov/pubmed/37162774
http://dx.doi.org/10.7759/cureus.37253
work_keys_str_mv AT buckmanpatrickj peripheralneuropathysecondarytoertapenemadministrationfortreatmentofinfectiousendocarditis
AT scattoncarly peripheralneuropathysecondarytoertapenemadministrationfortreatmentofinfectiousendocarditis
AT cappolajamesj peripheralneuropathysecondarytoertapenemadministrationfortreatmentofinfectiousendocarditis